Schwartz Aharon bought Protalix BioTherapeutics ($PLX) shares once on the open market in the last year, for a total of about $206,000, with the latest purchase on June 10, 2025. This ranks him 1,510th among nearly 5,000 insiders by purchase value, below the average of $1.5 million across about 3.3 transactions per insider. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 3, 2025 | Protalix BioTherapeutics, Inc. | $PLX | Schwartz Aharon | Not found | A | Common Stock | 7500 | $0.00 | 310,500.0000 | 81,271,610 | 2.48% | 0.01% |
| Sept. 3, 2025 | Protalix BioTherapeutics, Inc. | $PLX | Schwartz Aharon | Not found | A | Stock Options (Right to Buy) | 15000 | $0.00 | 15,000.0000 | 81,271,610 | 9999.99% | 0.02% |
| June 10, 2025 | Protalix BioTherapeutics, Inc. | $PLX | Schwartz Aharon | Not found | P | Common Stock | 129000 | $1.60 | 303,000.0000 | 76,611,980 | 74.14% | 0.17% |
| Sept. 29, 2023 | Protalix BioTherapeutics, Inc. | $PLX | Schwartz Aharon | Not found | A | Stock Option (Right to Buy) | 61676 | $0.00 | 61,676.0000 | 83,200,641 | 9999.99% | 0.07% |
| Jan. 3, 2023 | Protalix BioTherapeutics, Inc. | $PLX | Schwartz Aharon | Director | P | Common Stock | 110000 | $1.42 | 174,000.0000 | 48,472,159 | 171.88% | 0.23% |